Gynecologic Cancers Treatment Options

• Minimally invasive and robotic surgery, which uses smaller incisions than a traditional open procedure, resulting in less blood loss, reduced pain, shorter recovery time and quicker return to normal activities
• Advanced radiation therapy delivery that is more focused on cancerous cells with less exposure on surrounding normal tissues
• Fertility-preserving therapy options for young women who want to preserve their fertility after cancer treatment
• Individually customized chemotherapy regimens, including novel drugs and drug combinations in our clinical trials program

Highlights of our OVARIAN CANCER treatment program include:

• Pelvic floor reconstruction procedures that can restore continence and reduce discomfort
• Image-guided radiation delivery systems that can accurately target radiation to tumor sites while minimizing exposure in normal, healthy tissues
• Fertility-preserving options for patients who wish to have children after cancer treatment
• Innovative ovarian cancer clinical trials with treatments that may be more effective and less toxic, including cancer-fighting viruses, immunity-boosting vaccine therapies and drugs that can overcome the cancer’s defense mechanisms

Highlights of our ENDOMETRIAL/UTERINE CANCER treatment program include:

• Minimally invasive and robotic surgery, which uses smaller incisions than a traditional open procedure, resulting in less blood loss, reduced pain, shorter recovery time and quicker return to normal activities
• Cytoreductive (debulking) surgery, which can improve outcomes and increase likelihood of a cure
• Advanced radiation therapy delivery that is more focused on cancerous cells with less exposure on surrounding normal tissues
• Fertility-preserving therapy options for young women who want to preserve their fertility after cancer treatment
• Intraperitoneal (IP) and heated intraperitoneal chemotherapy (HIPEC), which can improve outcomes for women with advanced cancers.

Learn more about additional treatment options for cervical, ovarian and endometrial/uterine cancers.